Intellipharmaceutics International Inc. (IPCIQ)

OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Jul 24, 2026
Market Cap33.00
Revenue (ttm)904.95K +2,410.5%
Net Income-3.17M
EPS-0.09
Shares Out 33.09M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100
Open0.000001
Previous Closen/a
Day's Range0.000001 - 0.000001
52-Week Range0.000001 - 0.000001
Beta1.26
Analystsn/a
Price Targetn/a
Earnings Daten/a

About IPCIQ

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 11
Stock Exchange OTCMKTS
Ticker Symbol IPCIQ
Full Company Profile